Replication Data for: Consensus clustering for case series identification and adverse event profiles in pharmacovigilance
<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a research archivist expert in dataset metadata. Answer the question truthfully.  <|eot_id|><|start_header_id|>user<|end_header_id|> Here is the Description of a dataset. Description:'Replication Data for: Consensus clustering for case series identification and adverse event profiles in pharmacovigilanceThis data was extracted from VigiBase, the WHO global database of individual case safety reports. Its reports are collected by national pharmacovigilance centres such as the US FDA, which are members of the WHO Programme for International Drug Monitoring. This study included data available in VigiBase on 27 December 2018, a total of 18.4 million reports, not counting suspected duplicates. This dataset includes data for three drugs, sumatriptan, ambroxol and tacrolimus (on reports in VigiBase drugs are encoded using the WHODrug dictionary for medicinal information). Data is provided in CSV files with header rows. Reports are encoded as sparse indices, where InstanceID[row_i] and AdverseEvent' . Please return only a json list of at most 3 Keywords corresponding to the Description:.<|eot_id|><|start_header_id|>assistant<|end_header_id|> {"Answer" : ["Adverse Drug Reaction Reporting Systems","Cluster Analysis","Methods","Pharmacovigilance"]} <|eot_id|>
 Here is the Description of a dataset. Description:'Replication Data for: Consensus clustering for case series identification and adverse event profiles in pharmacovigilanceThis data was extracted from VigiBase, the WHO global database of individual case safety reports. Its reports are collected by national pharmacovigilance centres such as the US FDA, which are members of the WHO Programme for International Drug Monitoring. This study included data available in VigiBase on 27 December 2018, a total of 18.4 million reports, not counting suspected duplicates. This dataset includes data for three drugs, sumatriptan, ambroxol and tacrolimus (on reports in VigiBase drugs are encoded using the WHODrug dictionary for medicinal information). Data is provided in CSV files with header rows. Reports are encoded as sparse indices, where InstanceID[row_i] and AdverseEvent' . Please return only a json list of at most 3 Keywords corresponding to the Description:.
Replication Data for: Consensus clustering for case series identification and adverse event profiles in pharmacovigilanceThis data was extracted from VigiBase, the WHO global database of individual case safety reports. Its reports are collected by national pharmacovigilance centres such as the US FDA, which are members of the WHO Programme for International Drug Monitoring. This study included data available in VigiBase on 27 December 2018, a total of 18.4 million reports, not counting suspected duplicates. This dataset includes data for three drugs, sumatriptan, ambroxol and tacrolimus (on reports in VigiBase drugs are encoded using the WHODrug dictionary for medicinal information). Data is provided in CSV files with header rows. Reports are encoded as sparse indices, where InstanceID[row_i] and AdverseEvent
Adverse Drug Reaction Reporting Systems; Cluster Analysis; Methods; Pharmacovigilance